Biochemical and clinical analysis of accumulated glycolipids in symptomatic heterozygotes of angiokeratoma corporis diffusum (Fabry's disease) in comparison with hemizygotes.
Angiokeratoma corporis diffusum (Fabry's disease) is an X-linked disorder of glycosphingolipid catabolism. Heterozygous females, although usually asymptomatic, are occasionally as severely afflicted as hemizygous males; recently we identified a heterozygous patient with cardiomyopathy and severe pain in the extremities. In order to elucidate the difference of the clinical features, we analyzed the glycolipid composition of the heart, liver, and kidney obtained from the patient and from a hemizygote. Gas-liquid chromatography revealed that globotriaosylceramide (Gb3) was markedly increased in the heart (32.4 times higher than control) and increased to a lesser extent in the liver and kidney (3.74 and 6.79 times, respectively). The pattern of Gb3 accumulation in the heterozygote, where the highest increases were seen in the heart, was distinct from that in the hemizygote, where elevated levels of Gb3 and Ga2 were found in the kidney. Furthermore, the alpha-galactosidase activity in the heart, liver, and kidney of the heterozygote was 17%, 26%, and 36%, respectively, of normal controls, which correlated well with the accumulation of glycosphingolipid in the heart and with the disease's clinical manifestations. Two other hemizygotic patients, who were identified by low alpha-galactosidase activities, demonstrated the cardiac involvement.
Hozumi
I
I
Department of Neurology, Niigata University, Japan.
Nishizawa
M
M
Ariga
T
T
Miyatake
T
T
D000293:Adolescent; D000328:Adult; D000795:Fabry Disease / Q000235:genetics / Q000378:metabolism*; D005260:Female; D005732:Gangliosides / Q000378:metabolism; D005838:Genotype; D005915:Globosides / Q000378:metabolism; D006017:Glycolipids / Q000378:metabolism*; D006028:Glycosphingolipids / Q000378:metabolism; D006579:Heterozygote; D006801:Humans; D008247:Lysosomes / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D014018:Tissue Distribution; D014281:Trihexosylceramides
D005732:Gangliosides; D005915:Globosides; D006017:Glycolipids; D006028:Glycosphingolipids; D014281:Trihexosylceramides; C018549:globotriaosylceramide; C054370:galabiosylceramide